Drug profile · INN
dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells)
SHINGRIX
dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells) (SHINGRIX) is a envelope glycoprotein e vaccine antigen.
PMDA: approved
Patents linked 0
Pipeline programs 15
News articles 0
Drug details — dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells)
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 15
- Data quality
- 0.78
Quick answer
dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells) (SHINGRIX) is a envelope glycoprotein e vaccine antigen.
Key facts
INN dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells)
Brand SHINGRIX
Mechanism Envelope glycoprotein E vaccine antigen
Target Envelope glycoprotein E
Mechanism of action
Envelope glycoprotein E vaccine antigen
Primary target: Envelope glycoprotein E
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells)?
dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells) (SHINGRIX) is a envelope glycoprotein e vaccine antigen.
What is the brand name for dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells)?
SHINGRIX is a marketed brand name for dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells). Check FDA Drugs@FDA for the current US label holder and prescribing information.